The cholesterol lowering drug lovastatin induces cell death in myeloma plasma cells
- 1 July 2002
- journal article
- Published by Springer Nature in Leukemia
- Vol. 16 (7) , 1362-1371
- https://doi.org/10.1038/sj.leu.2402501
Abstract
Leukemia is one of the leading journals in hematology and oncology. It is published monthly and covers all aspects of the research and treatment of leukemia and allied diseases. Studies of normal hemopoiesis are covered because of their comparative relevance.Keywords
This publication has 39 references indexed in Scilit:
- Follow-up study of patients randomized in the scandinavian simvastatin survival study (4S) of cholesterol loweringThe American Journal of Cardiology, 2000
- Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptorsOncogene, 2000
- New Insights into the Interaction of Ras with the Plasma MembraneCell, 1999
- Long‐term bone marrow cultured stromal cells regulate myeloma tumour growthin vitro: studies with primary tumour cells and LTBMC‐dependent cell linesBritish Journal of Haematology, 1998
- Protein Prenylation, et cetera--Signal Transduction in Two DimensionsScience, 1997
- Co‐Iigation of ICAM‐1 (CD54) and membrane IgM negatively affects B cell receptor signalingEuropean Journal of Immunology, 1995
- Effects of lovastatin on a human myeloma cell line: increased sensitivity of a multidrug-resistant subline that expresses the 170 kDa P-glycoproteinAnti-Cancer Drugs, 1994
- Modulation of multidrug-resistant multiple myeloma by cyclosporinThe Lancet, 1992
- Regulation of the mevalonate pathwayNature, 1990
- Ras oncogene mutation in multiple myeloma.The Journal of Experimental Medicine, 1989